US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 1.410
  • +0.040+2.92%
Close May 17 16:00 ET
  • 1.410
  • -0.001-0.04%
Post 16:21 ET
58.58MMarket Cap-721P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Carisma Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

3.40M

+4.75%
EPS(YoY)

-0.46

+76.17%
Analyst Rating

Strong Buy

May 15, 2024

Carisma Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 4.299M--
--2024/Q2-- / 3.924M--
--2024/Q13.397M / 4.396M--
--2023/Q44.289M / 2.907M--
--2023/Q33.827M / 890.000K--
--2023/Q23.560M / 3.243M--
--2023/Q13.243M / 3.731M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 4.299M--
--2024/Q2-- / 3.924M--
--2024/Q13.397M / 4.396M--
--2023/Q44.289M / 2.907M--
--2023/Q33.827M / 890.000K--
--2023/Q23.560M / 3.243M--
--2023/Q13.243M / 3.731M--
--------
--------
--------

Unlock Free Earnings Estimates

Carisma Therapeutics Earnings Reports

  • Carisma Therapeutics | 10-Q: Quarterly report

    May 9 19:57

  • Carisma Therapeutics | 10-K: Annual report

    Apr 1 20:51

  • Carisma Therapeutics | 10-Q: Quarterly report

    Nov 9, 2023 21:36

  • Carisma Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 20:36

    • Read more

    Analysis

    Analyst Rating

    Updated: May 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg